Published

Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychiatry research
Date: 2023-11-01
Source: PubMed
DOI: 10.1016/j.psychres.2023.115531
PubMed: 37844352

Authors

Haikazian S Chen-Li DCJ Johnson DE Fancy F Levinta A Husain MI Mansur RB McIntyre RS Rosenblat JD

Watch author

Derived topics and classifications

psilocybin Depression End-of-Life Distress Clinical Trial Meta-Analysis Systematic Review Review Article Meta-Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 13 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14 Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization2026-05-13 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06 Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols2026-04-01 Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01 Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy2026-03-01 Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression2026-03-01 Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms2025-11-25

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17